Mankind 7 Pharma IPO Today Opening: price, review, other details, Best Deal 2023

Mankind 7 Pharma IPO( original public offering) is opening for subscription now and the public issue worth ₹ 4,326.36 crore will remain open for bidding till 27th April 2023. The pharma company, which has over 36 brands including Manforce and Prega News, has fixed Mankind Pharma IPO price band at ₹ 1026 to ₹ 1080 per equity share. Mankind Pharma IPO, which is fully OFS( offer for trade) in nature had made its debut in slate request before hitting the primary request on Dalal Street,buy And not. According to request spectators, shares of humanity Pharma are available at a decoration of ₹ 90 in slate request moment.

mankind pharma

1] Mankind Pharma IPO date:

  • The public issue has opened today and it will remain open for bidding till 27th April 2023.

2] Mankind Pharma IPO price band: 

Manforce and Prega News maker company has fixed price band of its public offer at ₹1026 to ₹1080 apiece.

3] Mankind Pharma IPO GMP: 

According to market observers, Mankind Pharma IPO GMP today is ₹100, which is ₹15 higher from its Monday GMP of ₹75 per shares.

4] Mankind Pharma IPO lot size:

 A bidder will be able to apply in lots and one lot of the IPO will comprise 13 shares.

5] Mankind Pharma IPO investment limit: 

As one lot will have 13 company shares, minimum amount required for a retail investor to apply for Mankind Pharma IPO is ₹14,040 ( ₹1080 x 13).

6] Mankind Pharma IPO allotment date: 

Most likely date for share allocation is 3rd May 2023.

7) Mankind Pharma IPO:-

register Kfin Technologies Limited has been appointed as authorized register of the IPO.

8) Mankind Pharma IPO:-

listing The public issue has been proposed for listing on both BSE and NSE.

9) Mankind Pharma IPO:-

menu date The public issue is likely to list on NSE and BSE on 8th May 2023.

10) Mankind Pharma IPO :-

Deal or not On mankind Pharma IPO review, Aditya Birla Capital said,” At the upper price band, MPL is available at PE 33x its hoped FY23 EPS. As at FY22, the D/ E stands at0.09 x while its Net Working Capital Cycle was at 49 days. We believe that MPL’s request leadership and brand recognition coupled with Management’s bet on the recent accession of Panacea Biotech’s phrasings may give a huge growth occasion for the company. We’ve a SUBSCRIBE recommendation to this issue.”

mankind pharma petstar

More About Read:-

10 things you should know about buying IPO shares:-

  • What is an IPO: An IPO, or Initial Public Offering, is the process by which a company offers its shares to the public for the first time, allowing investors to buy ownership stakes in the company.
  • Research the Company: Before investing in an IPO, it’s essential to research the company thoroughly. This includes understanding its business model, financials, competitive landscape, and growth prospects. Look for information in the company’s prospectus, financial statements, and other sources.
  • Prospectus: The prospectus is a legal document that provides detailed information about the company’s financials, business operations, risks, and other important disclosures. It’s important to read and understand the prospectus before investing in an IPO.
  • Risks: Investing in IPO shares can be risky as the company may be new, and its financials may not be well-established. There may also be uncertainties about the future performance of the stock. It’s important to be aware of the risks involved and assess them carefully before investing.
  • Valuation: IPO shares are priced by the company and its underwriters. It’s important to evaluate the valuation of the IPO shares to determine if they are reasonably priced. Comparing the valuation of the IPO with similar companies in the industry can be helpful.
  • Lock-up Period: Many IPOs have a lock-up period during which company insiders, such as founders and early investors, are prohibited from selling their shares. This can impact the stock’s liquidity and price performance. Be aware of any lock-up periods associated with the IPO.
  • Underwriters: IPOs are typically managed by underwriters, which are investment banks that help the company go public. The underwriters play a crucial role in the IPO process and can provide valuable information about the company and the IPO shares.
mankind pharma best things
  • Allocation: Getting an allocation of IPO shares can be challenging, as demand often exceeds supply. It’s important to understand the allocation process and the factors that determine how shares are allocated, such as the size of your investment, your relationship with the underwriters, and other criteria.
  • Trading: IPO shares are initially traded on the secondary market after they are listed on a stock exchange. It’s important to understand the trading dynamics of IPO shares, including bid-ask spreads, market liquidity, and price volatility, as they can impact your investment.
  • Long-term Perspective: IPO investing should be approached with a long-term perspective. The stock price may be volatile in the short term, and it may take time for the company to establish its performance in the public markets. It’s important to have a clear investment plan and be patient with your investment in IPO shares.

Related Articles

Back to top button